
A proven framework for CDMO selection in pharma and biotech, with scorecards, due diligence checklists, and governance KPIs — updated April 2026 with BIOSECURE Act, Catalent/Novo deal, and EU GMP Annex 1 impacts.

A proven framework for CDMO selection in pharma and biotech, with scorecards, due diligence checklists, and governance KPIs — updated April 2026 with BIOSECURE Act, Catalent/Novo deal, and EU GMP Annex 1 impacts.

Explore the Bid Defense Meeting (BDM), a critical step for CROs to win clinical trial contracts. Updated for 2026 with ICH E6(R3) guidance, AI-driven bid tools, and current CRO market data. Learn key preparation strategies, sponsor criteria, and best practices.

Learn what a CRDMO is and how this integrated model combines CRO and CDMO services. Updated for 2026 with BIOSECURE Act impact, latest market data, and industry M&A

A detailed 2025 analysis of the GxP managed services market for pharma & life sciences. Learn about trends, regulatory drivers, and GxP compliance challenges.
© 2026 IntuitionLabs. All rights reserved.